Article: Sphingolipids in neurodegenerative diseases.
2023 Volume 17, Page(s) 1137893
Abstract: Neurodegenerative Diseases (NDDs) are a group of disorders that cause progressive deficits of neuronal function. Recent evidence argues that sphingolipid metabolism is affected in a surprisingly broad set of NDDs. These include some lysosomal storage ... ...
Abstract | Neurodegenerative Diseases (NDDs) are a group of disorders that cause progressive deficits of neuronal function. Recent evidence argues that sphingolipid metabolism is affected in a surprisingly broad set of NDDs. These include some lysosomal storage diseases (LSDs), hereditary sensory and autonomous neuropathy (HSAN), hereditary spastic paraplegia (HSP), infantile neuroaxonal dystrophy (INAD), Friedreich's ataxia (FRDA), as well as some forms of amyotrophic lateral sclerosis (ALS) and Parkinson's disease (PD). Many of these diseases have been modeled in |
---|---|
Language | English |
Publishing date | 2023-02-16 |
Publishing country | Switzerland |
Document type | Journal Article ; Review |
ZDB-ID | 2411902-7 |
ISSN | 1662-453X ; 1662-4548 |
ISSN (online) | 1662-453X |
ISSN | 1662-4548 |
DOI | 10.3389/fnins.2023.1137893 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.